Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.045 AUD
−86.40 M AUD
6.48 M AUD
1.36 B
About Botanix Pharmaceuticals Limited
Sector
Industry
CEO
Howie McKibbon
Website
Headquarters
West Perth
Founded
1984
ISIN
AU000000BOT2
FIGI
BBG000BB1YZ8
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BOT is 0.150 AUD — it has increased by 3.57% in the past 24 hours. Watch Botanix Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Botanix Pharmaceuticals Limited stocks are traded under the ticker BOT.
BOT stock has risen by 16.00% compared to the previous week, the month change is a −9.38% fall, over the last year Botanix Pharmaceuticals Limited has showed a −58.90% decrease.
We've gathered analysts' opinions on Botanix Pharmaceuticals Limited future price: according to them, BOT price has a max estimate of 2.00 AUD and a min estimate of 0.27 AUD. Watch BOT chart and read a more detailed Botanix Pharmaceuticals Limited stock forecast: see what analysts think of Botanix Pharmaceuticals Limited and suggest that you do with its stocks.
BOT stock is 9.49% volatile and has beta coefficient of 1.85. Track Botanix Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Botanix Pharmaceuticals Limited there?
Today Botanix Pharmaceuticals Limited has the market capitalization of 274.59 M, it has increased by 18.18% over the last week.
Yes, you can track Botanix Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Botanix Pharmaceuticals Limited is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
BOT earnings for the last half-year are −0.03 AUD per share, whereas the estimation was −0.01 AUD, resulting in a −200.00% surprise. The estimated earnings for the next half-year are −0.02 AUD per share. See more details about Botanix Pharmaceuticals Limited earnings.
Botanix Pharmaceuticals Limited revenue for the last half-year amounts to 5.41 M AUD, despite the estimated figure of 3.33 M AUD. In the next half-year revenue is expected to reach 15.50 M AUD.
BOT net income for the last half-year is −55.51 M AUD, while the previous report showed −30.89 M AUD of net income which accounts for −79.71% change. Track more Botanix Pharmaceuticals Limited financial stats to get the full picture.
No, BOT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Botanix Pharmaceuticals Limited EBITDA is −80.68 M AUD, and current EBITDA margin is −1.24 K%. See more stats in Botanix Pharmaceuticals Limited financial statements.
Like other stocks, BOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Botanix Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Botanix Pharmaceuticals Limited technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Botanix Pharmaceuticals Limited stock shows the sell signal. See more of Botanix Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.